Makoto Sugita, MD, PhD, MBA
About Makoto Sugita, MD, PhD, MBA
Makoto Sugita, MD, PhD, MBA, is the Vice President of R&D Japan at Bristol Myers Squibb, with extensive experience in the pharmaceutical industry and a diverse educational background.
Current Position at Bristol Myers Squibb
Makoto Sugita currently holds the position of Vice President, R&D Japan at Bristol Myers Squibb. Based in Tokyo, Japan, he is responsible for overseeing research and development activities within the region. His role involves leading critical projects and initiatives to advance the company's scientific and medical objectives.
Previous Roles at Parexel and Johnson & Johnson
Before joining Bristol Myers Squibb, Makoto Sugita served as Senior Vice-President & General Manager - Japan at Parexel from 2019 to 2020. Prior to this, he had a significant tenure at Johnson & Johnson, where he was Regional Leader of Integrated Team for Medical, Clinical and Regulatory in ASPAC Medical Devices from 2018 to 2019, and Vice President from 2016 to 2018. In these roles, he contributed to clinical and regulatory strategies, as well as regional business units.
Experience at Janssen Pharmaceutical K.K.
At Janssen Pharmaceutical K.K., Makoto Sugita led R&D and Scientific Affairs from 2010 to 2016. During this six-year period, he was instrumental in driving research and development initiatives, focusing on advancing the company's pharmaceutical pipeline and scientific innovations.
Educational Background
Makoto Sugita has a diverse educational background. He earned his MD and PhD from 東北大学, studying medicine from 1987 to 1993 and philosophy from 1993 to 1997. He then pursued an MBA in General Management from McGill University from 2007 to 2009. Additionally, he studied Math at Washington University in St. Louis, earning an AB from 1983 to 1986. He completed his high school education at Shattuck School from 1981 to 1983.
Academic Contributions at Kanazawa Medical University
Makoto Sugita served as an Assistant Professor at Kanazawa Medical University from 2002 to 2006. During his four-year tenure, he contributed significantly to academic and medical education, enriching the curriculum and mentoring future medical professionals.